Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Moss

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Biochemistry|May 16, 2002
The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic propertiesNeil Justin, Nicola Walker, Helen L Bullifent, et al.
Protein Science : a Publication of the Protein Society|March 19, 2013
Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studiesMonika Bokori-Brown, Maria C Kokkinidou, Christos G Savva, et al.
Vaccine|April 9, 2014
Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemiaMonika Bokori-Brown, Charlotte A Hall, Charlotte Vance, et al.
Journal of Molecular Biology|October 22, 2003
Clostridium absonum alpha-toxin: new insights into clostridial phospholipase C substrate binding and specificityGraeme C Clark, David C Briggs, Tadahiro Karasawa, et al.
Elife|July 7, 2022
An entropic safety catch controls hepatitis C virus entry and antibody resistanceLenka Stejskal, Mphatso D Kalemera, Charlotte B Lewis, et al.
Briefings in Bioinformatics|April 23, 2009
ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimizationFrancesco Pappalardo, Mark D Halling-Brown, Nicolas Rapin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 5, 2010
ImmunoGrid: towards agent-based simulations of the human immune system at a natural scaleMark Halling-Brown, Francesco Pappalardo, Nicolas Rapin, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Biochemistry|May 16, 2002
The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic propertiesNeil Justin, Nicola Walker, Helen L Bullifent, et al.
Protein Science : a Publication of the Protein Society|March 19, 2013
Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studiesMonika Bokori-Brown, Maria C Kokkinidou, Christos G Savva, et al.
Vaccine|April 9, 2014
Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemiaMonika Bokori-Brown, Charlotte A Hall, Charlotte Vance, et al.
Journal of Molecular Biology|October 22, 2003
Clostridium absonum alpha-toxin: new insights into clostridial phospholipase C substrate binding and specificityGraeme C Clark, David C Briggs, Tadahiro Karasawa, et al.
Elife|July 7, 2022
An entropic safety catch controls hepatitis C virus entry and antibody resistanceLenka Stejskal, Mphatso D Kalemera, Charlotte B Lewis, et al.
Briefings in Bioinformatics|April 23, 2009
ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimizationFrancesco Pappalardo, Mark D Halling-Brown, Nicolas Rapin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 5, 2010
ImmunoGrid: towards agent-based simulations of the human immune system at a natural scaleMark Halling-Brown, Francesco Pappalardo, Nicolas Rapin, et al.
Pageof 4